Exchange Traded Concepts, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

$4.74 Billion
Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 6,159 shares of REGN stock, worth $4.37 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,159

Previous 4,020 53.21%

Holding current value

$4.37 Million

Previous $4.23 Million 3.83%

% of portfolio

0.09%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$701.85 - $1046.91 $1.5 Million - $2.24 Million	2,139 Added 53.21%	6,159 $4.39 Million
Q3 2024 Oct 10, 2024	BUY	$1024.09 - $1201.76 $109,577 - $128,588	107 Added 2.73%	4,020 $4.23 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $674,764 - $818,389	764 Added 24.26%	3,913 $4.11 Million
Q1 2024 Apr 15, 2024	SELL	$902.69 - $993.35 $1.63 Million - $1.79 Million	-1,805 Reduced 36.44%	3,149 $3.03 Million
Q4 2023 Jan 05, 2024	BUY	$775.18 - $881.7 $946,494 - $1.08 Million	1,221 Added 32.71%	4,954 $4.35 Million
Q3 2023 Oct 18, 2023	SELL	$692.45 - $844.37 $317,834 - $387,565	-459 Reduced 10.95%	3,733 $3.07 Million
Q2 2023 Jul 20, 2023	SELL	$700.03 - $830.35 $140,006 - $166,070	-200 Reduced 4.55%	4,192 $3.01 Million
Q1 2023 Apr 12, 2023	SELL	$680.49 - $826.97 $2.04 Million - $2.48 Million	-2,993 Reduced 40.53%	4,392 $3.61 Million
Q4 2022 Jan 17, 2023	BUY	$705.89 - $766.39 $2.31 Million - $2.5 Million	3,266 Added 79.29%	7,385 $5.33 Million
Q3 2022 Oct 07, 2022	BUY	$573.97 - $724.32 $234,179 - $295,522	408 Added 10.99%	4,119 $2.84 Million
Q2 2022 Jul 20, 2022	SELL	$548.35 - $738.84 $823,073 - $1.11 Million	-1,501 Reduced 28.8%	3,711 $2.19 Million
Q1 2022 Apr 26, 2022	BUY	$595.12 - $698.43 $396,945 - $465,852	667 Added 14.68%	5,212 $3.64 Million
Q4 2021 Jan 13, 2022	SELL	$543.48 - $670.97 $297,283 - $367,020	-547 Reduced 10.74%	4,545 $2.87 Million
Q3 2021 Oct 18, 2021	SELL	$574.03 - $680.96 $999,960 - $1.19 Million	-1,742 Reduced 25.49%	5,092 $3.08 Million
Q2 2021 Jul 30, 2021	SELL	$472.8 - $558.54 $31,204 - $36,863	-66 Reduced 0.96%	6,834 $3.82 Million
Q1 2021 Apr 20, 2021	BUY	$446.73 - $548.2 $1.32 Million - $1.62 Million	2,957 Added 74.99%	6,900 $3.27 Million
Q4 2020 Jan 19, 2021	BUY	$478.3 - $607.98 $1.12 Million - $1.42 Million	2,343 Added 146.44%	3,943 $1.91 Million
Q3 2020 Oct 30, 2020	BUY	$544.75 - $658.21 $271,285 - $327,788	498 Added 45.19%	1,600 $896,000
Q2 2020 Jul 15, 2020	BUY	$493.32 - $643.92 $396,629 - $517,711	804 Added 269.8%	1,102 $687,000
Q1 2020 Apr 14, 2020	BUY	$336.18 - $494.43 $21,515 - $31,643	64 Added 27.35%	298 $146,000
Q4 2019 Jan 22, 2020	BUY	$274.13 - $376.51 $64,146 - $88,103	234 New	234 $88,000

Others Institutions Holding REGN

# of Institutions

1,484

Shares Held

83.7M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Regeneron Pharmaceuticals, Inc. Transaction History